MitoQ for the Treatment of Metabolic Dysfunction in Asthma
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
A 14-week, randomized, placebo-controlled, double-masked clinical trial in 40 obese patients
with poorly controlled asthma.
The intervention is Mitoquinol (MitoQ) versus placebo.
The primary aim of this pilot study is to determine if MitoQ improves airway reactivity in
obese patients with asthma.